Alnylam Pharmaceuticals, Inc $(ALNY)$ is currently at $362.53, up $39.03 or 12.06%
--Would be highest close since Jan. 22, 2026, when it closed at $370.00
--On pace for largest percent increase since July 31, 2025, when it rose 15.43%
--Currently up eight consecutive days; up 24.42% over this period
--Longest winning streak since Oct. 20, 2025, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending Aug. 11, 2025, when it rose 28.02%
--Up 20.43% month-to-date
--Down 8.83% year-to-date
--Down 26.2% from its all-time closing high of $491.22 on Oct. 20, 2025
--Up 12.36% from 52 weeks ago (July 10, 2025), when it closed at $322.64
--Down 26.2% from its 52-week closing high of $491.22 on Oct. 20, 2025
--Up 30.36% from its 52-week closing low of $278.09 on June 18, 2026
--Traded as high as $380.00; highest intraday level since Jan. 9, 2026, when it hit $409.58
--Up 17.47% at today's intraday high; largest intraday percent increase since July 31, 2025, when it rose as much as 18.43%
--Second best performer in the Nasdaq 100 today
All data as of 10:06:42 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 09, 2026 10:08 ET (14:08 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.